Aurora Cannabis Company supplies record breaking cannabis products worth $ 8 million to Israel

Canadian cannabis producer Aurora Cannabis Inc. announced on July 15 that it had officially delivered one of the largest shipments of cannabis to Israel to date.

The company completed a record-breaking shipment, defined as “nearly $ 8 million” – one of the company’s largest shipments. “We are pleased with the development of the cannabis industry in Israel and commend the Ministry of Health and the Israeli Medical Cannabis Agency for ensuring well-thought-out regulation of cannabis in the best interests of Israeli cannabis patients,” said Aurora Cannabis Inc’s Chief Executive Officer .Miguel Martin.

He continued, “We look forward to continuing to deliver high quality cannabis to Israel as part of our strategy to expand our medical cannabis portfolio in key international markets.”

Aurora Cannabis Inc. has been supplying Israel-based Cantek Global Ltd., a leading medical cannabis company, with dried cannabis flowers for several months under a strategic supply agreement that the two companies entered into. The agreement, which was officially announced in November 2020, provides that at least 4,000 kg of dried flowers must be shipped to Israel in large quantities annually for a total of two years, with the option of a later extension.

In a press release, Martin praised the two companies’ ability to expand their international cannabis brands and make history. “The point is for the strength and quality of the Aurora medical brand to be reaffirmed by the medical cannabis markets around the world, including countries like Israel, where we have not had any distribution to date. We consider this agreement a significant step for Aurora and look forward to bringing our high quality medical cannabis products to patients in Israel. ”Cantek Global Ltd. maintains partnerships with “local drugstore chains, sales companies, clinics”.

Aurora Cannabis is an international cannabis brand

Aurora Cannabis Inc., a big player in the Canadian cannabis industry as well as around the world, has also grown into a major flower producer for the German cannabis market, although part of its European workforce had to be hired as early as July 2020 on May 25th that began Company officially trading on the Nasdaq Global Select Market under the ticker symbol “ACB” (which is separate from its listing on the Toronto Stock Exchange as “TSX: ACB”).

In June, the company was asked by BNN Bloomberg about its pursuit of unique genetics to differentiate itself from other Canadian competitors. “We have a lot of great genetics to work on, but we’re already going beyond what we had,” said Charles Pick, Aurora’s senior vice president of science and innovation. “We take plants that are already super interesting, we cross them and can produce hundreds, if not thousands of seeds.”

Like many cannabis companies, Aurora issued a statement in support of the federal cannabis law recently proposed by the United States. “The introduction of the Cannabis Administration and Opportunity Act marks a turning point in public policy related to cannabis in the United States. Aurora welcomes this proposed legislation and what its adoption would mean for the health, wellbeing and livelihoods of millions of Americans – especially colored communities and all those disproportionately affected by cannabis bans, penalties and persistent stigma, ”the company wrote Twitter on.

“As one of the largest licensed cannabis producers in Canada – and the world – Aurora is no stranger to a regulatory company with national scope. We are ready and willing to work with lawmakers in the United States to make continued progress toward cannabis policy that prioritizes safety, wellbeing, justice, and common sense. With this legislation in place, we hope that cannabis policy in the United States will evolve and will soon reflect the overwhelming support of the American public for legalization. “